|
|
|
Volumn 5, Issue 5, 2007, Pages 352-354
|
|
The role of statins in vascular protection
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
CERIVASTATIN;
EZETIMIBE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MEVINOLIN;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
SIMVASTATIN;
TISSUE PLASMINOGEN ACTIVATOR;
ANGIOGENESIS INHIBITOR;
ANGIOGENESIS;
ANTIANGIOGENIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
APOPTOSIS;
ARTICLE;
ATHEROSCLEROSIS;
BLOOD CLOTTING;
CLINICAL TRIAL;
COMORBIDITY;
DRUG DOSE TITRATION;
DRUG MECHANISM;
DRUG PROTEIN BINDING;
DRUG SAFETY;
ENDOTHELIAL DYSFUNCTION;
ENZYME INHIBITION;
FIBRINOLYSIS;
HEART PROTECTION;
HIGH RISK PATIENT;
HUMAN;
HYPERLIPIDEMIA;
IMMUNOMODULATION;
ISCHEMIC HEART DISEASE;
LOW DRUG DOSE;
MYOSITIS;
NONHUMAN;
OXIDATIVE STRESS;
PLEIOTROPY;
PROTEIN EXPRESSION;
RISK REDUCTION;
THROMBOCYTE AGGREGATION INHIBITION;
VASCULAR ENDOTHELIUM;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
INFLAMMATION;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
ANGIOGENESIS INHIBITORS;
ENDOTHELIUM, VASCULAR;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INFLAMMATION;
MYOSITIS;
|
|
EID: 34548619483
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (7)
|
